26.83
+0.25(+0.94%)
Currency In USD
| Previous Close | 26.58 |
| Open | 26.58 |
| Day High | 26.91 |
| Day Low | 26.39 |
| 52-Week High | 30.5 |
| 52-Week Low | 14.4 |
| Volume | 221,201 |
| Average Volume | 854,222 |
| Market Cap | 1.78B |
| PE | -7.94 |
| EPS | -3.38 |
| Moving Average 50 Days | 26.28 |
| Moving Average 200 Days | 22.72 |
| Change | 0.25 |
If you invested $1000 in Celldex Therapeutics, Inc. (CLDX) 10 years ago, it would be worth $111.51 as of December 25, 2025 at a share price of $26.83. Whereas If you bought $1000 worth of Celldex Therapeutics, Inc. (CLDX) shares 5 years ago, it would be worth $1,533.14 as of December 25, 2025 at a share price of $26.83.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Celldex Initiates Global Registrational Phase 3 Program of Barzolvolimab in Cold Urticaria and Symptomatic Dermographism
GlobeNewswire Inc.
Dec 09, 2025 1:01 PM GMT
No advanced therapies approved to treat ColdU and SD—diseases of misery that dramatically impact all aspects of patient lifeBarzolvolimab is the only drug in development to demonstrate clinical benefit in patients in ColdU and SD in a large, randomiz
Celldex Announces Appointment of Teri Lawver as Chief Commercial Officer
GlobeNewswire Inc.
Nov 10, 2025 1:01 PM GMT
HAMPTON, N.J., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ: CLDX) today announced the appointment of Teri Lawver as Senior Vice President, Chief Commercial Officer. Ms. Lawver is an accomplished global healthcare executive with 30 years of st
Celldex to Present at Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 07, 2025 1:01 PM GMT
HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences: Guggenheim 2nd Annual Healthcare Innovation Conference on Tues